We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Plantar Stimulation on Hypotension, Treatment Efficacy and Quality of Life With Adults on Hemodialysis

This study has been withdrawn prior to enrollment.
(Original principal investigator left the university before enrollment started)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00822653
First Posted: January 14, 2009
Last Update Posted: September 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Kenneth McLeod, Binghamton University
  Purpose
For the end stage renal disease (ESRD) patients undergoing hemodialysis treatment, specifically, reflex mediated calf muscle pump stimulation has the potential to significantly reduce the number and magnitude of hypotensive episodes thus enhancing the effectiveness of the dialysis process. Fewer hemodialysis complications during the patient's hemodialysis treatment, would allow treatment sessions to continue to the prescribed volume removal, with much reduced patient recovery time, and the costs associated with this recovery.

Condition Intervention
Hypotension Device: Calf Muscle Pump Stimulation

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: the Effects of Plantar Stimulation on Hypotension, Treatment Efficacy and Quality of Life

Resource links provided by NLM:


Further study details as provided by Kenneth McLeod, Binghamton University:

Primary Outcome Measures:
  • Achievement of ultrafiltration goal [ Time Frame: 6 weeks ]
    Fraction of dialysis treatments where microfiltration target was achieved during 6 week period


Secondary Outcome Measures:
  • Hypotensive events [ Time Frame: 6 weeks ]
    Number of hypotensive events experienced during dialysis over six week time period


Enrollment: 0
Study Start Date: June 2008
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Calf Muscle Pump Stimulation
Subjects serve as self-control. Six weeks of dialysis data without intervention will be compared to six weeks post intervention
Device: Calf Muscle Pump Stimulation
Stimulation of the postural reflex arc to activate the soleus muscle during dialysis

Detailed Description:

Recruit individuals who consistently miss their dialysis goal. Maintain the goal over a six week period of time. Utilize exogenous calf muscle pump stimulation during each dialysis session to enhance fluid return from the lower limbs with the objective of assisting the patient in reaching ultrafiltration goal.

Track number of hypotensive events during dialysis, as well as goal success.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. 18 years of age or older;
  2. alert and oriented to time, place, and self;
  3. able to read and speak the English language;
  4. currently receiving hemodialysis treatment approximately 3-4 hour sessions, 3 times a week;
  5. received hemodialysis treatments continuously for the several previous months; AND
  6. consistently exhibits hypotensive symptoms during dialysis.

Exclusion Criteria:

  1. receiving hemodialysis as a temporary treatment following a peritoneal dialysis complication or an episode of transplant rejection;
  2. receiving hemodialysis at home; OR
  3. if they have a Medical History of any the following conditions: deep venous thrombosis, uncontrolled hypertension, pulmonary embolus
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00822653


Sponsors and Collaborators
Binghamton University
Investigators
Principal Investigator: Kenneth J. McLeod, Ph.D. Clinical Science and Engineering Research Center
  More Information

Responsible Party: Kenneth McLeod, Professor, BioEngineering, Binghamton University
ClinicalTrials.gov Identifier: NCT00822653     History of Changes
Other Study ID Numbers: 521-07
First Submitted: January 13, 2009
First Posted: January 14, 2009
Last Update Posted: September 26, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Team is willing to share anonymous data with interested investigators

Keywords provided by Kenneth McLeod, Binghamton University:
hemodialysis treatment
pump stimulation
reduce hypotensive episodes

Additional relevant MeSH terms:
Hypotension
Vascular Diseases
Cardiovascular Diseases